Condition Lookup

Parkinson’s disease

Specialty: Senior Health and Geriatrics

Category: Neurological and Cognitive Disorders

Symptoms:
tremors at rest; bradykinesia (slowness of movement); muscle rigidity; postural instability; difficulty with balance and coordination; shuffling gait; speech changes; cognitive decline (in advanced stages)

Root Cause:
Degeneration of dopamine-producing neurons in the substantia nigra of the brain, leading to reduced dopamine levels and impaired movement control.

How it's Diagnosed: videos
Diagnosis is based on clinical symptoms, neurological examination, and medical history. Imaging tests such as MRI or CT scans may be used to rule out other conditions, but diagnosis is primarily clinical.

Treatment:
Medications to increase or mimic dopamine, physical therapy, occupational therapy, and in some cases, surgical interventions like deep brain stimulation.

Medications:
Common medications include levodopa (a precursor to dopamine), dopamine agonists (e.g., pramipexole , ropinirole ), and MAO-B inhibitors (e.g., selegiline ). Levodopa is classified as a dopaminergic agent, while dopamine agonists are categorized as antiparkinsonian drugs.

Prevalence: How common the health condition is within a specific population.
Affects approximately 1% of individuals over the age of 60, with an increasing prevalence as the population ages.

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Age (higher risk in older adults), family history, male gender, environmental exposures (e.g., pesticides), and genetic mutations.

Prognosis: The expected outcome or course of the condition over time.
Progressive disease with varying rates of progression. Many individuals live for many years with the condition, but quality of life can be significantly impacted.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Cognitive decline (dementia), difficulty swallowing (dysphagia), depression, sleep disturbances, and an increased risk of falls.

Essential tremor

Specialty: Senior Health and Geriatrics

Category: Neurological and Cognitive Disorders

Sub-category: Movement Disorders

Symptoms:
rhythmic tremor (shaking) in hands, head, voice, or other body parts; tremors worsen with movement or when holding something; difficulty with fine motor tasks (e.g., writing, eating)

Root Cause:
A neurodegenerative condition that affects the cerebellum, leading to abnormal signals causing tremors, though the exact cause remains unclear.

How it's Diagnosed: videos
Diagnosis is clinical, based on the presence of a tremor that worsens with voluntary movement. Neuroimaging is typically used to rule out other causes of tremor.

Treatment:
Treatment may involve medications like beta-blockers (propranolol), anticonvulsants (primidone), or botulinum toxin injections. In severe cases, deep brain stimulation surgery may be considered.

Medications:
Beta-blockers (propranolol ) and anticonvulsants (primidone ) are commonly prescribed. These medications are classified as anti-tremor agents and are used to reduce the intensity of tremors.

Prevalence: How common the health condition is within a specific population.
Affects approximately 4-5% of people over the age of 40, with a higher prevalence in those over 65.

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Family history (essential tremor is often hereditary), age, and in some cases, environmental exposures.

Prognosis: The expected outcome or course of the condition over time.
It is generally not life-threatening but is a progressive condition that can worsen over time, especially if untreated.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Impairment in daily functioning (e.g., difficulty writing, eating, and dressing), social embarrassment, and anxiety related to tremor severity.

Huntington’s disease (late-onset cases)

Specialty: Senior Health and Geriatrics

Category: Neurological and Cognitive Disorders

Sub-category: Movement Disorders

Symptoms:
chorea (involuntary jerky movements); dystonia (muscle contractions); cognitive decline; psychiatric symptoms (depression, irritability, anxiety); difficulty with speech and swallowing; unsteady gait

Root Cause:
A genetic neurodegenerative disorder caused by mutations in the HTT gene, leading to the accumulation of abnormal huntingtin protein, which damages brain cells in regions controlling movement and cognition.

How it's Diagnosed: videos
Diagnosis is confirmed through genetic testing, which identifies the mutation in the HTT gene. Clinical evaluation includes assessment of movement disorders, cognitive decline, and psychiatric symptoms.

Treatment:
There is no cure, but symptoms can be managed. Medications for movement symptoms (e.g., tetrabenazine, antipsychotics for chorea), antidepressants, and cognitive therapies.

Medications:
Tetrabenazine (for chorea) and antipsychotic medications like olanzapine or risperidone may be prescribed. These drugs are classified as neuroleptics or antipsychotic agents, and tetrabenazine is a vesicular monoamine transporter 2 inhibitor.

Prevalence: How common the health condition is within a specific population.
Late-onset Huntington’s disease is rare but typically affects individuals in their 40s or later. The overall prevalence of Huntington's disease is about 3 to 7 per 100,000 people worldwide.

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Inherited mutation in the HTT gene, with an autosomal dominant inheritance pattern. Age of onset is usually in mid-life for late-onset cases.

Prognosis: The expected outcome or course of the condition over time.
Progressive disease, with a gradual decline in motor, cognitive, and psychiatric functions. Individuals typically live 10 to 20 years after the onset of symptoms.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Cognitive decline, psychiatric issues (depression, suicidal thoughts), difficulty swallowing (increased risk of aspiration), and mobility impairments.